References
- Huhn AS, Hobelmann JG, Strickland JC, Oyler GA, Bergeria CL, Umbricht A, Dunn KE. Differences in availability and use of medications for opioid use disorder in residential treatment settings in the United States. JAMA Network Open. 2020 Feb 7;3(2):e1920843–e1920843. doi:https://doi.org/10.1001/jamanetworkopen.2019.20843.
- Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Medication treatment for opioid use disorders in substance use treatment facilities. Health Aff. 2019 Jan;38(1):14–23. doi:https://doi.org/10.1377/hlthaff.2018.05162.
- Friedman SR, Williams LD, Guarino H, Mateu-Gelabert P, Krawczyk N, Hamilton L, Karen M, Herman J . The stigma system: how sociopolitical domination, scapegoating, and stigma shape public health. J Community Psychol [Internet]. [accessed 2021 Jun 28];n/a(n/a). [Internet] http://onlinelibrary.wiley.com/doi/abs/10.1002/jcop.22581
- McElrath K, Joseph H. Medication-Assisted Treatment (MAT) for opioid addiction: introduction to the special issue. Subst Use Misuse. 2018 Jan 28;53(2):177–80. doi: https://doi.org/10.1080/10826084.2017.1404106.
- Uebelacker LA, Bailey G, Herman D, Anderson B, Stein M. Patients’ beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification. J Subst Abuse Treat. 2016 Jul 1;66:48–53. doi:https://doi.org/10.1016/j.jsat.2016.02.009.
- Wakeman SE, Rich JD. Barriers to medications for addiction treatment: how stigma kills. Subst Use Misuse. 2018 Jan 28;53(2):330–33. doi: https://doi.org/10.1080/10826084.2017.1363238.
- Roman PM, Abraham AJ, Knudsen HK. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict Behav. 2011 Jun 1;36(6):584–89. doi: https://doi.org/10.1016/j.addbeh.2011.01.032.
- Wakeman SE. Medications for addiction treatment: changing language to improve care. J Addict Med. 2017 Feb;11(1):1–2. doi:https://doi.org/10.1097/ADM.0000000000000275.
- Corrigan PW, Watson AC, Barr L. The self–stigma of mental illness: implications for self–esteem and self–efficacy. J Soc Clin Psychol. 2006 Oct;25(8):875–84. doi:https://doi.org/10.1521/jscp.2006.25.8.875.
- Luoma JB, Twohig MP, Waltz T, Hayes SC, Roget N, Padilla M, Fisher G. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav. 2007 Jul 1;32(7):1331–46. doi:https://doi.org/10.1016/j.addbeh.2006.09.008.
- McCradden MD, Vasileva D, Orchanian-Cheff A, Buchman DZ. Ambiguous identities of drugs and people: a scoping review of opioid-related stigma. Int J Drug Pol. 2019 Dec 1;74:205–15. doi:https://doi.org/10.1016/j.drugpo.2019.10.005.
- Tuliao A, Holyoak D. Psychometric properties of the perceived stigma towards substance users scale: factor structure, internal consistency, and associations with help-seeking variables. Am J Drug Alcohol Abuse. 2019 Sep 6;46:1–9. doi:https://doi.org/10.1080/00952990.2019.1686760.
- Heath PJ, Brenner RE, Lannin DG, Vogel DL. Self-compassion moderates the relationship of perceived public and anticipated self-stigma of seeking help. Stigma Health. 2018;3(1):65–68.doi:https://doi.org/10.1037/sah0000072.
- Henderson C, Evans-Lacko S, Thornicroft G. Mental illness stigma, help seeking, and public health programs. Am J Public Health. 2013 May 1;103(5):777–80. doi: https://doi.org/10.2105/AJPH.2012.301056.
- Smith LR, Mittal ML, Wagner K, Copenhaver MM, Cunningham CO, Earnshaw VA. Factor structure, internal reliability and construct validity of the methadone maintenance treatment stigma mechanisms scale (MMT-SMS). Addiction. 2020 Feb;115(2):354–67. doi:https://doi.org/10.1111/add.14799.
- Andraka-Christou B, Capone MJ. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices. Int J Drug Pol. 2018 Apr 1;54:9–17. doi:https://doi.org/10.1016/j.drugpo.2017.11.021.
- Mittal D, Drummond KL, Blevins D, Curran G, Corrigan P, Sullivan G. Stigma associated with PTSD: perceptions of treatment seeking combat veterans. Psychiatr Rehabil J. 2013;36(2):86–92.doi:https://doi.org/10.1037/h0094976.
- Luoma JB, O’Hair AK, Kohlenberg BS, Hayes SC, Fletcher L. The development and psychometric properties of a new measure of perceived stigma toward substance users. Subst Use Misuse. 2010;45(1–2):47–57.doi:https://doi.org/10.3109/10826080902864712.
- van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013 Jul 1;131(1):23–35. doi: https://doi.org/10.1016/j.drugalcdep.2013.02.018.
- Mittal D, Owen RR, Ounpraseuth S, Chekuri L, Drummond KL, Jennings MB, Smith JL, Sullivan JG, Corrigan PW. Targeting stigma of mental illness among primary care providers: findings from a pilot feasibility study. Psychiatry Res. 2020 Feb 1;284:112641. doi:https://doi.org/10.1016/j.psychres.2019.112641.
- Kopera M, Suszek H, Bonar E, Myszka M, Gmaj B, Ilgen M, Wojnar M. Evaluating explicit and implicit stigma of mental illness in mental health professionals and medical students. Community Ment Health J. 2015 Jul 1;51(5):628–34. doi:https://doi.org/10.1007/s10597-014-9796-6.
- Charles JLK, Bentley KJ. Measuring mental health provider-based stigma: development and initial psychometric testing of a self-assessment instrument. Community Ment Health J. 2018 Jan;54(1):33–48. doi:https://doi.org/10.1007/s10597-017-0137-4.
- Palamar JJ, Kiang MV, Halkitis PN. Development and psychometric evaluation of scales that assess stigma associated with illicit drug users. Subst Use Misuse. 2011;46(12):1457–67.doi:https://doi.org/10.3109/10826084.2011.596606.
- Johnson-Kwochka A, Aalsma MC, Monahan PO, Salyers MP. Development and examination of the attribution questionnaire-substance use disorder (AQ-SUD) to measure public stigma towards adolescents experiencing substance use disorders. Drug Alcohol Depend. 2021 Apr 1;221:108600. doi:https://doi.org/10.1016/j.drugalcdep.2021.108600.
- Yang LH, Grivel MM, Anderson B, Bailey GL, Opler M, Wong LY, Stein MD. A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: evidence for construct validity. J Subst Abuse Treat. 2019 Apr 1;99:44–51. doi:https://doi.org/10.1016/j.jsat.2019.01.005.
- Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health [Internet]. 2018 [cited 2021 Mar 11];6. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2018.00149/full#B127
- Howard MC. A review of exploratory factor analysis decisions and overview of current practices: what we are doing and how can we improve? Int Jo Human Comp Interaction. 2016 Jan 2;32(1):51–62. doi: https://doi.org/10.1080/10447318.2015.1087664.
- Baldwin SA. Psychological statistics and psychometrics using Stata. First ed. College Station, Texas: Stata Press; 2019. p. 454.
- Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36(1):559–74.doi:https://doi.org/10.1146/annurev-publhealth-031914-122957.
- Brown RL, Moloney ME, Brown J. Gender differences in the processes linking public stigma and self-disclosure among college students with mental illness. J Community Psychol. 2018;46(2):202–12.doi:https://doi.org/10.1002/jcop.21933.
- Seidler ZE, Dawes AJ, Rice SM, Oliffe JL, Dhillon HM. The role of masculinity in men’s help-seeking for depression: a systematic review. Clin Psychol Rev. 2016 Nov1;49:106–18. doi:https://doi.org/10.1016/j.cpr.2016.09.002.
- Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013 Aug 1;131(3):263–70. doi: https://doi.org/10.1016/j.drugalcdep.2012.11.018.